(Q55475412)

English

Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.

scientific article published in January 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

Adaptive radiation therapy

0 references

author name string

R Kirla

1

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

E Salminen

2

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

S Huhtala

3

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

J Nuutinen

4

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

L Talve

5

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

H Haapasalo

6

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

H Kalimo

7

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

46

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

1

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

71-80

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

https://scigraph.springernature.com/pub.10.1023/a:1006473320474

0 references

Detection of p16 gene deletions in gliomas: a comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A molecular genetic model of astrocytoma histopathology

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlative immunohistochemistry and molecular genetic study of the inactivation of the p16INK4A genes in astrocytomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subsets of glioblastoma multiforme defined by molecular genetic analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CDKN2/p16 inactivation and p16 immunohistochemistry in astrocytic gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical detection of CDKN2, retinoblastoma and p53 gene products in primary astrocytic tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The p53 gene and its role in human brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of p53 gene and protein alterations in human astrocytic tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of P16INK4 expression is frequent in high grade gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular genetics and molecular biology advances in brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The p53 gene and protein in human brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivariate analysis of prognostic factors in 106 patients with malignant glioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deletion of p16 and p15 genes in brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896207

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1006473320474

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/10896207

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55475412&oldid=1609390080"